Abeona Therapeutics Inc. (ABEO)

Abeona Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	15.73	14.47	14.22	32.94	12.6	129.26
Short-Term Investments	93.98	37.75	37.93	12.09	82.44	-
Cash & Short-Term Investments	109.7	52.23	52.15	45.02	95.03	129.26
Cash Growth	104.08%	0.15%	15.82%	-52.62%	-26.48%	52.13%
Accounts Receivable	-	-	-	3	-	-
Other Receivables	1.61	2.44	0.19	-	-	-
Receivables	1.61	2.44	0.19	3	-	-
Prepaid Expenses	1.01	0.73	0.42	2.38	2.71	3.13
Restricted Cash	0.34	0.34	0.34	5.89	-	-
Total Current Assets	112.66	55.74	53.1	56.29	97.74	132.39
Property, Plant & Equipment	7.85	7.99	11.07	21.74	18.35	21.2
Goodwill	-	-	-	-	32.47	32.47
Other Intangible Assets	-	-	-	1.38	1.5	36.18
Other Long-Term Assets	0.09	0.28	0.04	0.17	1.14	1.14
Total Assets	120.59	64	64.21	79.59	151.2	223.38
Accounts Payable	2.79	1.86	1.81	4.33	4.7	3.76
Accrued Expenses	5.21	5.99	3.99	5.59	3.41	5.54
Current Portion of Long-Term Debt	4.44	-	-	-	0.33	-
Current Portion of Leases	1.06	1	1.77	1.82	1.71	1.7
Current Unearned Revenue	-	-	-	-	0.3	0.3
Other Current Liabilities	4.92	4.58	0.2	4.9	31.52	27.4
Total Current Liabilities	18.42	13.42	7.78	16.62	41.96	38.7
Long-Term Debt	14.21	-	-	-	1.43	-
Long-Term Leases	3.4	4.4	5.85	7.56	5.26	6.25
Other Long-Term Liabilities	38.79	31.35	23.82	13.04	-	-
Total Liabilities	74.82	49.18	37.45	37.22	48.65	44.95
Common Stock	0.43	0.27	0.18	1.47	0.96	0.84
Additional Paid-In Capital	849.39	764.15	722.05	696.56	672.3	664.06
Retained Earnings	-803.97	-749.52	-695.34	-655.64	-570.7	-486.47
Comprehensive Income & Other	-0.08	-0.07	-0.13	-0.03	-0.01	-
Total Common Equity	45.77	14.83	26.76	42.37	102.55	178.43
Shareholders' Equity	45.77	14.83	26.76	42.37	102.55	178.43
Total Liabilities & Equity	120.59	64	64.21	79.59	151.2	223.38
Total Debt	23.11	5.4	7.63	9.38	8.73	7.95
Net Cash (Debt)	86.59	46.83	44.52	35.65	86.3	121.31
Net Cash Growth	80.17%	5.17%	24.90%	-58.70%	-28.86%	42.77%
Net Cash Per Share	2.45	2.19	5.66	9.05	23.28	60.23
Filing Date Shares Outstanding	43.47	27.36	17.71	5.9	3.95	3.34
Total Common Shares Outstanding	43.4	26.52	17.72	5.89	3.85	3.34
Working Capital	94.24	42.32	45.32	39.67	55.78	93.69
Book Value Per Share	1.05	0.56	1.51	7.20	26.67	53.34
Tangible Book Value	45.77	14.83	26.76	40.98	68.59	109.79
Tangible Book Value Per Share	1.05	0.56	1.51	6.96	17.84	32.82
Machinery	9.69	7.92	9.02	10.98	9.98	8.74
Construction In Progress	-	-	-	3.22	0.07	-
Leasehold Improvements	8.81	8.6	8.61	8.6	8.6	8.57

Source: S&P Capital IQ. Standard template. Financial Sources.